RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)

CUSIP: 75629V104

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class
Equity / Class A Stock
Total 13F shares
251,836,128
Total 13F value
$1,888,574,788
Holder snapshot 6 visible 7 signals
Share change
+40,762,649
Put/Call ratio
248%
SEC-reported price per share
$7.50
Number of holders
264
Value change
+$298,622,706
Number of buys
174
Open additional details 1 more signal available
Number of sells
94
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
525,302,736

Security key

75629V104

Report period

Q2 2024

Institutions

264

Top holders

10

RXRX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2024 Previous quarter: Q1 2024 RECURSION PHARMACEUTICALS, INC. SEC filings RECURSION PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F 3/4/5 Lead comparable stake: 28% Showing 1-6 of 15 holder rows.

Quick read

VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 28%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership Top 5
VIKING GLOBAL INVESTORS LP 28%
Anchorage Capital Group, L.L.C. 13%
SB INVESTMENT ADVISERS (UK) LTD 4.7%
GLENVIEW CAPITAL MANAGEMENT, LLC 4.6%
Mubadala Investment Co PJSC 2.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VIKING GLOBAL INVESTORS LP
13F
Company
13F
28%
$165,978,746
143,085,126 shares
 — 31 Mar 2024
Anchorage Capital Group, L.L.C.
13F
Company
13F
13%
$81,031,328
69,854,593 shares
 — 31 Mar 2024
SB INVESTMENT ADVISERS (UK) LTD
13F
Company
13F
4.7%
$28,337,862
24,429,191 shares
 — 31 Mar 2024
GLENVIEW CAPITAL MANAGEMENT, LLC
13F
Company
13F
4.6%
$27,840,000
24,000,000 shares
 — 31 Mar 2024
Mubadala Investment Co PJSC
3/4/5 13F
10%+ Owner · Company
3/4/5 13F
2.5%
from 13F
$137,333,970
12,985,927 shares
 — 02 Mar 2023
Kinnevik AB (publ)
13F
Company
13F
2%
$103,744,510
10,405,668 shares
 — 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
264
Shares
251,836,128
Rows available
264
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
242
Q2 2024 holders
264
Holder diff
22
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .